VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 127 filers reported holding VAXCYTE INC in Q3 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $698,252 | -26.0% | 18,630 | -5.4% | 0.02% | -47.7% |
| Q4 2022 | $944,183 | +124.8% | 19,691 | +12.5% | 0.04% | +238.5% |
| Q3 2022 | $420,000 | +10.2% | 17,504 | -5.0% | 0.01% | +18.2% |
| Q2 2022 | $381,000 | -7.3% | 18,423 | +7.9% | 0.01% | +37.5% |
| Q1 2022 | $411,000 | +1.2% | 17,081 | +7.1% | 0.01% | 0.0% |
| Q4 2021 | $406,000 | -17.3% | 15,954 | -16.3% | 0.01% | -11.1% |
| Q3 2021 | $491,000 | +43.6% | 19,056 | +25.7% | 0.01% | +50.0% |
| Q2 2021 | $342,000 | +17.5% | 15,155 | -2.9% | 0.01% | +20.0% |
| Q1 2021 | $291,000 | -59.5% | 15,606 | -37.0% | 0.01% | -68.8% |
| Q4 2020 | $718,000 | -51.6% | 24,782 | -13.9% | 0.02% | -66.0% |
| Q3 2020 | $1,482,000 | – | 28,778 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $90,711,000 | 29.04% |
| Medicxi Ventures Management (Jersey) Ltd | 3,774,956 | $82,142,000 | 17.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 832,166 | $18,108,000 | 9.12% |
| GREAT POINT PARTNERS LLC | 985,153 | $21,437,000 | 5.14% |
| Kynam Capital Management, LP | 723,781 | $15,749,000 | 4.02% |
| Ghost Tree Capital, LLC | 325,000 | $7,072,000 | 3.68% |
| Frazier Life Sciences Management, L.P. | 1,787,405 | $38,894,000 | 3.67% |
| RA Capital Management | 4,581,203 | $99,687,000 | 2.66% |
| Opaleye Management Inc. | 190,000 | $4,134,000 | 1.86% |
| Soleus Capital Management, L.P. | 370,650 | $8,065,000 | 1.26% |